| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 107 |
| 1 | PACLITAXEL | 70 |
| 2 | PACLITAXEL (AIBUMIN-BOUND) | 68 |
| 3 | OXALIPLATIN | 28 |
| 4 | CAPECITABINE | 26 |
| 5 | PREDNISOLONE | 24 |
| 6 | PREDNISOLONE ORAL | 24 |
| 7 | PREDNISOLONE ORAL SOLUTION | 24 |
| 8 | CYCLOPHOSPHAMIDE | 17 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLAVOXATE HYDROCHLORIDE | 1 | 0.0099 |
| 1 | CARTEOLOL HYDROCHLORIDE | 1 | 0.0030 |
| 2 | BODY CLEANSER | 2 | 0.0028 |
| 3 | STREPTOMYCIN | 3 | 0.0026 |
| 4 | TOREMIFENE CITRATE | 1 | 0.0023 |
| 5 | ADEFOVIR DIPIVOXIL | 2 | 0.0016 |
| 6 | PRALATREXATE | 1 | 0.0015 |
| 7 | RESMETIROM | 3 | 0.0013 |
| 8 | DISOPYRAMIDE PHOSPHATE | 1 | 0.0012 |
| 9 | AMILORIDE HYDROCHLORIDE | 1 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 107 |
| 1 | Microtubule Inhibitor [EPC] | 72 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 38 |
| 3 | Corticosteroid [EPC] | 35 |
| 4 | Platinum-based Drug [EPC] | 34 |
| 5 | Kinase Inhibitor [EPC] | 29 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 23 |
| 7 | Proton Pump Inhibitor [EPC] | 23 |
| 8 | Alkylating Drug [EPC] | 19 |
| 9 | Aromatase Inhibitor [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Hormone Receptor beta Agonist [EPC] | 3 | 0.0013 |
| 1 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 7 | 0.0011 |
| 2 | Leptin Analog [EPC] | 1 | 0.0008 |
| 3 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 107 | 0.0006 |
| 5 | Microtubule Inhibitor [EPC] | 72 | 0.0004 |
| 6 | Bile Acid [EPC] | 9 | 0.0004 |
| 7 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 8 | Antimycobacterial [EPC] | 8 | 0.0003 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 23 | 0.0002 |